Deborah Harland - Net Worth and Insider Trading
Deborah Harland Net Worth
The estimated net worth of Deborah Harland is at least $49 Million dollars as of 2024-09-20. Deborah Harland is the Director of Bicycle Therapeutics PLC and owns about 1,915,275 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $49 Million. Details can be seen in Deborah Harland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deborah Harland has not made any transactions after 2019-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deborah Harland
Deborah Harland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deborah Harland owns 1 companies in total, including Bicycle Therapeutics PLC (BCYC) .
Click here to see the complete history of Deborah Harland’s form 4 insider trades.
Insider Ownership Summary of Deborah Harland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-28 | director |
Deborah Harland Latest Holdings Summary
Deborah Harland currently owns a total of 1 stock. Deborah Harland owns 1,915,275 shares of Bicycle Therapeutics PLC (BCYC) as of May 28, 2019, with a value of $49 Million.
Latest Holdings of Deborah Harland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCYC | Bicycle Therapeutics PLC | 2019-05-28 | 1,915,275 | 25.40 | 48,647,985 |
Holding Weightings of Deborah Harland
Deborah Harland Form 4 Trading Tracker
According to the SEC Form 4 filings, Deborah Harland has made a total of 0 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years. The most-recent trade in Bicycle Therapeutics PLC is the acquisition of 385,714 shares on May 28, 2019, which cost Deborah Harland around $5 Million.
Insider Trading History of Deborah Harland
- 1
Deborah Harland Trading Performance
GuruFocus tracks the stock performance after each of Deborah Harland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deborah Harland is -45.11%. GuruFocus also compares Deborah Harland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deborah Harland within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deborah Harland's insider trading performs compared to the benchmark.
Performance of Deborah Harland
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.08 | | | | | |
| Relative Return to S&P 500(%) | -23.05 | | | | | |
Deborah Harland Ownership Network
Deborah Harland Owned Company Details
What does Bicycle Therapeutics PLC do?
Who are the key executives at Bicycle Therapeutics PLC?
Deborah Harland is the director of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .
Bicycle Therapeutics PLC (BCYC) Insider Trades Summary
Over the past 18 months, Deborah Harland made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 19,509 shares made by Kevin Lee , a net sale of 5,905 shares made by Michael Skynner , and a net sale of 5,905 shares made by Nigel Crockett .
In summary, during the past 3 months, insiders sold 7,268 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 7,268 shares. During the past 18 months, 44,258 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 44,258 shares.
Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bicycle Therapeutics PLC Insider Transactions
Deborah Harland Mailing Address
Above is the net worth, insider trading, and ownership report for Deborah Harland. You might contact Deborah Harland via mailing address: C/o Bicycle Therapeutics Limited, B900 Babraham Research Campus, Cambridge X0 Cb44 3at.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
